Inhibition of Corneal Neovascularization by Subconjunctival Injection of Fc-Endostatin, a Novel Inhibitor of Angiogenesis

Inhibition of Corneal Neovascularization by Subconjunctival Injection of Fc-Endostatin, a Novel Inhibitor of Angiogenesis

We assessed the antiangiogenic effects of subconjunctival injection of Fc-endostatin (FcE) using a human vascular endothelial growth factor-induced rabbit corneal neovascularization model. Angiogenesis was induced in rabbit corneas through intrastromal implantations of VEGF polymer implanted 2 mm fr...

Full description

Bibliographic Details
Main Authors:	Junko Yoshida, Robert T. Wicks, Andrea I. Zambrano, Betty M. Tyler, Kashi Javaherian, Rachel Grossman, Yassine J. Daoud, Peter Gehlbach, Henry Brem, Walter J. Stark
Format:	Article
Language:	English
Published:	Hindawi Limited 2015-01-01
Series:	Journal of Ophthalmology
Online Access:	http://dx.doi.org/10.1155/2015/137136

Similar Items

Resolution of Refractory Corneal Neovascularization with Subconjunctival Bevacizumab
by: Anna Krystyna Britton, et al.
Published: (2020-12-01)

Inhibition of Corneal Neovascularization by Topical and Subconjunctival Tigecycline
by: Sertan Goktas, et al.
Published: (2014-01-01)

Effects of topical and subconjunctival use of bevacizumab on corneal neovascularization in rabbits' eyes
by: Gerson Jorge Aparecido Lopes, et al.

Inhibitory effect of polysulfated heparin endostatin onalkali burn induced corneal neovascularization in rabbits
by: Zhao-Na Li, et al.
Published: (2015-04-01)

Comparison of different doses of subconjunctival sunitinib with bevacizumab in the treatment of corneal neovascularization in experimental rats
by: Mohammad Nasser Hashemian, et al.
Published: (2017-01-01)

Comparison of the effects of subconjunctival and topical anti-VEGF therapy (bevacizumab) on experimental corneal neovascularization
by: Ozdemir Ozdemir, et al.
Published: (2014-08-01)

The effect of subconjunctival bevacizumab on corneal neovascularization, inflammation and re-epithelization in a rabbit model
by: Glauco Reggiani Mello, et al.
Published: (2011-01-01)

Comparison of subconjunctivally injected bevacizumab, ranibizumab, and pegaptanib for inhibition of corneal neovascularization in a rat model
by: Cem Küçükerdönmez, et al.
Published: (2013-04-01)

Comparison of the inhibitory effect of different doses of subconjunctival bevacizumab application in an experimental model of corneal neovascularization
by: Burak Ulas, et al.
Published: (2018-07-01)

Angiogenesis: A special reference to corneal neovascularization
by: Nikolić Ljubiša, et al.
Published: (2015-01-01)

Short-term regression of corneal neovascularization with combination therapy of argon green laser photocoagulation and subconjunctival bevacizumab
by: Anand N, et al.
Published: (2019-04-01)

Studies on the Inhibitory Mechanism of Angiogenesis Inhibitor, endostatin
by: 陳恒琦
Published: (2000)

Studies on the Inhibitory Mechanism of Angiogenesis Inhibitor, Endostatin
by: Chen Heng-Chi, James, et al.
Published: (2000)

Studies on the Inhibitory Mechanism of Angiogenesis Inhibitor, Endostatin
by: Heng-Chi Chen, et al.

Topical versus subconjunctival anti-vascular endothelial growth factor therapy (Bevacizumab, Ranibizumab and Aflibercept) for treatment of corneal neovascularization
by: Tariq Al-Debasi, et al.
Published: (2017-04-01)

The Effect of Subconjunctival Bevacizumab on Angiogenesis in Rabbit Model
by: Nurwasis Nurwasis, et al.
Published: (2021-01-01)

Endostatin binds biglycan and LDL and interferes with LDL retention to the subendothelial matrix during atherosclerosis
by: Xiaokun Zeng, et al.
Published: (2005-09-01)

Comparison of endostatin(endostar)and avastin's inhibition effect on mice choroidal neovascularization
by: Jing Li, et al.
Published: (2014-06-01)

Inhibition of the recombinant human endostatin adenavirus on experimental choroidal neovascularization in rats
by: Li-Juan Chen, et al.
Published: (2017-06-01)

Two Endogenous Antiangiogenic Inhibitors, Endostatin and Angiostatin, Demonstrate Biphasic Curves in their Antitumor Profiles
by: Kashi Javaherian, et al.
Published: (2011-07-01)

The effects of the subconjunctival injection of bevacizumab (Avastin®) on angiogenesis in the rat cornea
by: Luiz F.M. Barros, et al.
Published: (2007-09-01)

Interactions between Endostatin and Vascular Endothelial Growth Factor (VEGF) and Inhibition of Choroidal Neovascularization
by: Chunhai Fan, et al.
Published: (2007-01-01)

Corneal neovascularization: An enigma
by: Pulkit Gupta, et al.
Published: (2013-01-01)

Study of endostatin, tumstatin and PEDF, the natural angiogenesis inhibitors, potential in avasculargenic therapy
by: V. G. Likhvantseva, et al.
Published: (2014-07-01)

Study of endostatin, tumstatin and PEDF, the natural angiogenesis inhibitors, potential in avasculargenic therapy
by: V. G. Likhvantseva, et al.
Published: (2014-07-01)

Subconjunctival bevacizumab and argon laser photocoagulation for preexisting neovascularization following deep lamellar anterior keratoplasty
by: Meena Lakshmipathy, et al.
Published: (2019-01-01)

Angiogenesis and vasculogenesis for therapeutic neovascularization
by: Murohara, Toyoaki
Published: (2003)

Meta-analysis of clinical effect of subconjunctival injection of vitamin C on corneal ulcer
by: Xiao-Zhuang Li, et al.
Published: (2021-08-01)

Evaluating the Efficacy of Topical and Subconjunctival Diclofenac in the Improvement of Corneal Alkali Burn in Rabbits
by: Noushin Esmaeeli, et al.
Published: (2016-12-01)

Apatinib-loaded nanoparticles suppress vascular endothelial growth factor-induced angiogenesis and experimental corneal neovascularization
by: Lee JE, et al.
Published: (2017-07-01)

Anti-angiogenic effects of a mutant endostatin: a new prospect for treating retinal and choroidal neovascularization.
by: Yujing Bai, et al.
Published: (2014-01-01)

Imaging methods of corneal neovascularization
by: Duo Xu, et al.
Published: (2019-08-01)

microRNAs in corneal neovascularization
by: Xiao-Ping Zhang, et al.
Published: (2020-01-01)

Therapeutic approaches for corneal neovascularization
by: Sepehr Feizi, et al.
Published: (2017-12-01)

Research on inhibition of corneal neovascularization
by: Zhang-Hui Yang, et al.
Published: (2015-12-01)

Circulating proangiogenic cytokines and angiogenesis inhibitor endostatin in untreated patients with chronic lymphocytic leukemia
by: Joanna Gora-Tybor, et al.
Published: (2003-01-01)

Recombinant human endostatin endostar suppresses angiogenesis and lymphangiogenesis of malignant pleural effusion in mice.
by: Xingqun Ma, et al.
Published: (2012-01-01)

Comparative study of the mode of therapy of iontophoresis of penicillin and subconjunctival soframycine in the treatment of corneal ulcers
by: Gulati G, et al.
Published: (1968-01-01)

Neovascularization, Angiogenesis and Vasculogenic Mimicry in Cancer
Published: (2020)

Subconjunctival emphysema
by: Antony Arokiadass Baskaran, et al.
Published: (2019-01-01)